Behind the Innovation
Roche Diagnostics recently brought its groundbreaking cobas i 601 Analyzer—the world’s first fully automated mass spectrometer—to market. This innovation is transforming clinical diagnostics by making high-performance mass spectrometry accessible to a broader range of healthcare providers. A key partner behind this revolutionary launch has been Avantor, which has brought its unique expertise in chemical manufacturing, packaging, and logistics to bear.
A Paradigm Shift in Diagnostics
The cobas i 601 consolidates the workload of multiple traditional mass spectrometry systems into a single, streamlined solution. It can process up to 100 samples per hour and eliminates the delays of batch-mode testing. This means clinicians receive results faster—often within hours instead of days—enabling quicker diagnoses and improved patient outcomes.
The system is designed for both experienced and new users of mass spectrometry. Smaller hospitals and regional labs can now perform complex diagnostics in-house, reducing reliance on external labs and democratizing access to advanced testing.
Avantor’s Expertise Powers the System
Avantor was selected as Roche’s contract manufacturing organization and original equipment manufacturer for four critical mass spectrometry system reagents: acetonitrile, methanol, a cleaning solution, and a custom ammonium fluoride blend. These reagents are essential to the operation of the cobas i 601 Analyzer, supporting cleaning, sample preparation, and purification.
What sets Avantor apart is its ability to produce LC-MS grade reagents at scale and package them in custom-designed bottles that meet Roche’s stringent quality and volume requirements. While Roche’s mass spectrometry offerings traditionally handled small, high-value quantities of chemicals, the cobas system required larger formats and higher throughput – areas where Avantor brought unmatched expertise.
Automation and Packaging Innovation
Avantor’s contributions extended beyond chemistry. To support the global launch of Roche’s cobas i 601 Analyzer, Avantor is transitioning from manual to automated filling lines at its facilities in Briare, France, and Gliwice, Poland. Avantor is also optimizing packaging by using pulp inserts and evaluating new box configurations to reduce manual labor and improve efficiency.
These improvements are paving the way for future automation of the packaging process and enabling direct shipments to Roche affiliates worldwide rather than a first stop at their central hub in Mannheim, Germany. This streamlines logistics, reduces costs, and enhances responsiveness to market demand.
A Trusted Partnership
The Roche–Avantor partnership is built on trust, transparency, and co-development. Avantor worked closely with Roche from the earliest stages to design reagents tailored to the cobas system’s unique specifications. The collaboration included joint testing, quality control, and transparent pricing models that broke down costs by raw materials, labor, and supply chain components.
Roche recognized Avantor’s value by inviting the company into its long-term growth supplier council—a select group of strategic partners involved in early-stage R&D discussions. Avantor’s role is so integral that its reagents are described as the 'fuel' powering the cobas i 601 Analyzer.
Delivering Value to Hospitals and Patients
By automating complex processes and enabling in-house diagnostics, the cobas i 601 helps hospitals reduce turnaround times and improve patient care. Clinicians can now run a wide range of tests from a single blood sample, receiving results quickly and efficiently. This is especially valuable for smaller hospitals that previously lacked the expertise or equipment to perform mass spectrometry.
Even when samples are sent to reference labs, the use of the cobas analyzer ensures faster processing and reporting. Ultimately, this innovation puts patients first by delivering timely insights that support better health outcomes.
Looking Ahead
As Roche gathers market feedback and scales the cobas i 601 Analyzer globally, Avantor remains a key partner in optimizing reagent production, packaging, and delivery. Together, the two companies are setting a new standard for diagnostic innovation—one that combines scientific excellence with operational efficiency.
Learn more about Avantor’s custom manufacturing capabilities.